Safety and Immunogenicity of Nanocovax, a SARS-CoV-2 Recombinant Spike Protein Vaccine
Author(s) -
Thuy Phuong Nguyen,
Quyết Đỗ,
Phan Trong Lan,
Duc V. Dinh,
Hiep Khong,
Luong Van Hoang,
Thượng Vũ Nguyễn,
Hung Pham Ngoc,
Men V. Chu,
Toàn Trọng Nguyễn,
Quang Duy Pham,
Minh-Tri Le,
Tuyen Thi Ngoc Trang,
Thanh Thi Dinh,
Thuong V. Vo,
Thao T. Vu,
Quynh B.P. Nguyen,
Vuong T. Phan,
Luong Viet Nguyen,
Giang T. Nguyen,
Phong M. Tran,
Thuan Duc Nghiem,
Tien Viet Tran,
Tien G. Nguyen,
Tuynh Quang Tran,
Linh Nguyen,
Anh Tuan,
Dung Dang Nguyen,
Son Anh Ho,
Thanh Nguyen,
Dung T. Pham,
Hieu Ba Tran,
Son Tung Vu,
Hoan Ngoc Vu,
Cuong Xuan Hoang,
Hoang Xuan Su,
Trung Minh,
Xuân Thanh Nguyễn,
Giang Quynh Le,
Ton Tran,
Minh Thang Cao,
Đào Huy Mạnh,
Thi Thanh Thao Nguyen,
Doan Y. Uyen,
Thi Tuong Vy Le,
Linh P. Tran,
Ngoc Minh Nguyen,
Ngoc Thu Nguyen,
Hang Pham,
Quan Nguyen,
Hieu Trung Nguyen,
Hang Le Khanh Nguyen,
Vinh The Tran,
Mai T. Tran,
Truc Thi Thanh Nguyen,
Phat T. Ha,
Hieu Trong Huynh,
Khanh Duy Tuan Nguyen,
Thuan Trong Ung,
Đoàn Chính Chung,
Minh Si
Publication year - 2021
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.3931736
Subject(s) - reactogenicity , medicine , immunogenicity , adverse effect , placebo , adjuvant , neutralizing antibody , immunology , virology , antibody , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom